Pharos Capital Makes Majority Investment in RhythMedix

January 4, 2024

Pharos Capital Group has acquired a majority stake in RhythMedix, a Mount Laurel, New Jersey-based maker of wearable cardiac monitoring devices and related services. RhythMedix's management is reinvesting and will remain in place; Pharos plans to support growth through increased R&D, market share expansion, and add-on acquisitions to broaden remote patient monitoring capabilities.

Buyers
Pharos Capital Group, LLC
Targets
RhythMedix
Industry
Medical Devices
Location
New Jersey, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.